newheader.jpg
 


Conference Menu

Overview
Pre-Conference Tutorial
Day 1
Day 2
Register
PDF Download
Hotel & Travel
Poster
Sponsor
Press Pass
Request Brochure
Send to a Colleague

Corporate Sponsors:

 

Corporate Support:

 
Lead Sponsoring Publication:
 
Sponsoring Publications:
 
Web Partners:


12:00-1:00 Conference Registration 

1:00-1:10 Welcoming Remarks from Conference Director 
Julia Boguslavsky, Cambridge Healthtech Institute 

microRNA Mechanism and Targets

1:10-1:15 Chairperson’s Opening Remarks 

1:15-1:45 miRNAs and HIV Infection 
Lars Aagaard, Ph.D., Division of Molecular Biology, Beckman Research Inst. of the City of Hope 
We have been investigating the profile of endogenous miRNA expression following HIV-1 infection of T-lymphocytes. One particular microRNA is routinely elevated following infection. In order to investigate the functional consequences of this upregulation, cellular targets for this have been identified and tested. In addition to the endogenous miRNA, we have strong data supporting the functional role HIV encoded TAR as a miRNA. The potential target for TAR has been identified and tested as well. This talk will focus on the target and its role in HIV infection. 

1:45-2:15 microRNAs Targeting Genomic Repeat Elements Within mRNAs 
Neil Smalheiser, M.D., Ph.D., Assistant Professor, Psychiatry, University of Illinois, Chicago 
Recently, we reported that four microRNAs show perfect complementarity with MIR/LINE-2 elements within human mRNAs. This finding raises the question of whether microRNAs might also target other genomic repeats and transposable elements. Here, we demonstrate that almost 30 human microRNAs exhibit typical short-seed complementarity with a specific site within Alu elements that is highly conserved within 3' untranslated regions of human mRNAs. The results suggest that at least some Alu elements within human mRNAs serve as microRNA targets. 

2:15-2:45 microRNA Regulatory Strategies of Human Cellular Networks 
Edwin Wang, Ph.D., Scientist, Biotechnology Research Institute, National Research Council Canada 
According to the dogma of molecular biology, RNAs are passive messengers and take charge of transferring genetic information only. However, the dogma has been challenged by the recent findings that microRNA (miRNA) is able to negatively regulate genes. It is estimated that 10%-30% of genes might be regulated by miRNAs. The diversity and abundance of miRNA targets offer an enormous level of combinatorial possibilities and suggest that miRNAs and their targets appear to form a complex regulatory network intertwined with other cellular networks. However, it is unclear if and how miRNAs might orchestrate their regulation of cellular networks and how regulation of these networks might contribute to the biological functions of miRNAs. Here we address these questions by analyzing the interactions between miRNAs and human cellular networks including signaling, metabolic and gene regulatory networks. We uncovered that in signaling networks, miRNAs predominantly target positive regulatory motifs, highly connected scaffolds and most downstream network components, but less frequently target negative regulatory motifs, common components of basic cellular machines and most upstream network components. In addition, when an adaptor has potential to recruit more downstream components, these components are more frequently targeted by miRNAs. These results imply that miRNAs have potential functions in facilitating robust transitions of cellular response to extracellular signals and maintaining cellular homeostasis. We also uncovered that through preferentially targeting the network nodes with distinct network structural features, microRNA regulates metabolic networks globally, regionally and locally to reduce or block specific metabolite production in a way of fine-tuning or directly blocking metabolic flows. This work uncovers the principles of miRNA regulation of cellular networks and generates a set of testable hypotheses. 

2:45-3:30 Refreshment Break with Exhibit and Poster Viewing 

3:30-3:50 Microrna Profiling Of Breast Cancer Using A Novel Locked Nucleic Acid (LNA) Based Microarray
Soren Moller, Ph.D, CSO, VP R&D, Exiqon A/S
To identify new biomarkers for breast cancer we studied the global expression of miRNAs in tumor and normal adjacent tissue. Using a microarray platform with LNA-modified capture probes we found numerous differentially expressed miRNAs, including those previously reported to be associated with breast cancer. The results were confirmed using miRCURY LNA qPCR. Further, we identified several novel miRNA candidates by 454-sequencing, some of which could have diagnostic and prognostic potential for breast cancer patients.

Sponsored by

3:50 Unravelling the Mystery of miRNA Targets
Vera Atzorn, Ph.D., Actigenics Marketing and Communication Manager, Cepheid
Even though microRNAs have been proven essential, their complete functional assessment remains a difficult task. This is mainly due to their molecular mode of action, which allows a single microRNA to impact the translation of hundreds of mRNAs. However, this apparent complexity refers to well defined interaction networks in which subgroups of microRNA regulate conjointly specific cellular events.miRgate, our all-in-one software solution, integrates network information regarding microRNAs and provides excellent filters to significantly enhance knowledge on real microRNA function.

Sponsored by

4:10 High Throughput microRNA Expression Profiling Using a Bead Based Multiplex System
Dr. Keld Sorensen, Director, R&D, Luminex Corporation
The combination of two technologies, namely the Locked Nucleic Acid (LNA ) and the bead based multiplexing (xMAP?), allows the design of miRNA assays that are both flexible and very specific. In brief, the assay consists of direct biotinylation of the 3' end of a sample of total RNA, followed by capture on LNA probes on the xMAP beads. The assays allow users up to 100 different capture probes in a singlemicrotiter well. With a total assay time of only a few hours, and the high level of multiplexing, the FlexmiR kits yield a throughput of thousands of data points per working day. Incorporating LNA technology within theoligonucleotide capture probes greatly increases the affinity of the probes fortheir complementary mature miRNA targets leading to significant increases anduniformity of assay specificity including single base discrimination of closely related miRNAs.

Sponsored by

Impact of Polymorphisms in microRNA Targets

4:30-5:00 Investigating the Impact of Variation on microRNA Target Sites 
Michael R. Barnes, Ph.D., Head, Molecular Discovery and Pharmacogenetic Bioinformatics, Molecular Discovery Informatics, GlaxoSmithKline Pharmaceuticals 
Accurate in silico microRNA (miRNA) target prediction in messenger RNA (mRNA) is a critical capability - we have evaluated different miRNA target prediction methods to empirically determine the determinants for miRNA binding to mRNA. In this context we have also evaluated the impact of SNP variation on the creation, strengthening, weakening and destruction of miRNA binding sites. This analysis has identified thousands of variants that may potentially impact miRNA regulation of mRNA. We believe this information may offer a real opportunity to study miRNA function at a number of levels. Firstly, sequence focused analysis will help to define the functional boundaries of miRNA target binding. Secondly, we may be able to identify miRNA target variants with a direct role in human disease. 

5:00-5:30 Polymorphisms in the 3’UTR of Human mRNAs Alter Regulation by microRNAs and Correlate With Human Behaviors 
Henry M. Furneaux, Ph.D., Associate Professor of Molecular, Microbial & Structural Biology; and Director, Graduate Program in Molecular Biology and Biochemistry, University of Connecticut Medical School 
The base pairing between a microRNA and mRNA target is critical for its function in gene regulation. We have investigated whether polymorphisms in human mRNAs may modulate regulation by microRNAs and thus contribute to diversity in human behavior. We have identified microRNA response elements in the mRNAs from genes encoding the Cannabinoid Receptor Type-1 (CNR1), Serotonin Receptor Type 1-B (HTR1B), Catechol-O-Methyl Transferase (COMT), GABA Receptor Alpha-2 subunit (GABRA2), Serotonin Receptor Type 2-C (HTR2C) and Serotonin Transporter (SLC6A4). We have shown that the common SNP rs13212041 disrupts the repression of the serotonin 1B receptor mRNA by mir-96, a brain specific microRNA. Thus, individuals who harbor this variant may lack the ability to repress their serotonin receptor 1B levels in response to brain stimuli. Indeed, in human population studies, we have found that this variant correlates with a reduced frequency of conduct disorder behaviors and an adolescent risk for substance dependence. 

5:30-6:30 Reception in the Exhibit Hall 

6:30 End of Day One 

foot.jpg


Cambridge Healthtech Institute| Beyond Genome | Bio-IT World | Biomarker World Congress | Cambridge Health Associates | Discovery On Target |
Health-IT World
| Bio-IT World Conference & Expo  | Molecular Medicine Tri-Conference | PEGS| PepTalk | Pharma DD
World Pharmaceutical Congress |

Your  Life Science Network

Cambridge Healthtech Institute  |  250 First Avenue  |  Suite 300   |   Needham,  MA  02494
Phone: 781-972-5400  |   Fax: 781-972-5425
chi@healthtech.com